newsfilter
← Latest News
Business Wire·

Baxalta Exceeds Guidance and Delivers Strong Sales and Earnings for First Quarter 2016

BANNOCKBURN, Ill.--(BUSINESS WIRE)--Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, today reported strong first quarter 2016 financial results.